Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,026 | -15,406 | -7,707 | -24,444 | -16,544 |
| Depreciation Amortization | -658 | -427 | -250 | -1,304 | -985 |
| Accounts receivable | -24 | 75 | -17 | 133 | 79 |
| Other Working Capital | 672 | -592 | -79 | 1,512 | 335 |
| Other Operating Activity | 2,739 | 1,603 | 904 | 2,027 | 1,473 |
| Operating Cash Flow | $-21,297 | $-14,747 | $-7,149 | $-22,076 | $-15,642 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,153 | 15,597 | 6,634 | 8,589 | 3,377 |
| PPE Investments | -34 | -18 | -12 | -25 | -18 |
| Investing Cash Flow | $-10,187 | $15,579 | $6,622 | $8,564 | $3,359 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8 | -5 | -3 | -9 | -6 |
| Common Stock Issued | 32,249 | 257 | 94 | 12,003 | 11,880 |
| Other Financing Activity | -456 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $31,785 | $252 | $91 | $11,994 | $11,874 |
| Beginning Cash Position | 3,025 | 3,025 | 3,025 | 4,543 | 4,543 |
| End Cash Position | 3,326 | 4,109 | 2,589 | 3,025 | 4,134 |
| Net Cash Flow | $301 | $1,084 | $-436 | $-1,518 | $-409 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,297 | -14,747 | -7,149 | -22,076 | -15,642 |
| Capital Expenditure | -34 | -18 | -12 | -25 | -18 |
| Free Cash Flow | -21,331 | -14,765 | -7,161 | -22,101 | -15,660 |